(Q44471337)
Statements
1 reference
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors (English)
1 reference
K Nakagawa
1 reference
T Tamura
1 reference
S Negoro
1 reference
S Kudoh
1 reference
N Yamamoto
1 reference
N Yamamoto
1 reference
K Takeda
1 reference
H Swaisland
1 reference
I Nakatani
1 reference
M Hirose
1 reference
R-P Dong
1 reference
M Fukuoka
1 reference
1 June 2003
1 reference
1 reference
Identifiers
1 reference